Press releases

• July 1, 2008 - Sciele Pharma Signs Agreement with Addrenex Pharmaceuticals To Develop and Market ADX415 for the Treatment of Hypertension
• July 1, 2008 - Addrenex Pharmaceuticals licenses new compound to Sciele Pharma for the treatment of hypertension and other potential indications
• June 3, 2008 - SCIELE PHARMA ANNOUNCES THAT ADDRENEX HAS COMPLETED ENROLLMENT OF PIVOTAL PHASE III TRIAL FOR CLONICEL FOR ADHD
• April 22, 2008 - SCIELE PHARMA ANNOUNCES FDA ACCEPTANCE OF NDA FOR ADDRENEX PHARMACEUTICALS' CLONIBID TO TREAT HYPERTENSION
• February 20, 2008 - Addrenex Pharmaceuticals Reaches Milestone with Filing of NDA for First Product, CloniBID, to Treat Hypertension
• February 20, 2008 - Sciele and Addrenex Announce NDA Submission for CloniBid to Treat Hypertension
• December 18, 2007 - Local Start-Up Acquires Rights to Large Portfolio of Potential New Drugs Through License Agreement with the University of Nebraska Medical Center
• October 30, 2007 - Multicenter Study Tests Hypertension Drug to Calm the “H” in ADHD
  “Hyper” has same root cause in hypertension and hyperactivity, study proposes.
• October 30, 2007 - Sciele Pharma and Addrenex Announce Initiation of Pivotal Phase III Trials for Clonicel for ADHD
• July 17, 2007 - PHARMACEUTICAL STARTUP SIGNS $6 MILLION DEAL IN ITS FIRST YEAR
• July 12, 2007 - Sciele Pharma Signs Agreement with Addrenex Pharmaceuticals to Market Clonicel®

Media Coverage

• July 2, 2008 - Durham, Atlanta companies partner. Drug venture could top $200 million
  By The News & Observer
• July 1, 2008 - Addrenex lands deal worth as much as $27M
  By Triangle Business Journal
• May 30, 2008 - Addrenex aims for fast track, Relatively young for drug company, it plans to create drugs to counter adrenaline
  By The News & Observer
• May 30, 2008 - Drug research offers family new choice
  By The News & Observer
• December 18, 2007 - UNMC licenses drugs to North Carolina Triangle Company
  By The Lincoln Journal Star
• December 19, 2007 - BRIEF: Addrenex to test potential medicines
  By BusinessWeek
• December 18, 2007 - Startup Addrenex Licenses Drug Technology from University of Nebraska
  By WRAL.com
• December 19, 2007 - Addrenex to test potential medicines
  By The News & Observer
• July 19, 2007 - “Idea for pill gets new backer” - Hypertension, ADHD are targets
  By The News & Observer